SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Cambridge Antibody Technology Group
An SI Board Since December 1999
Posts SubjectMarks Bans
625 23 0
Emcee:  Jongmans Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
475Read somewhere JnJ's il-12 mab showed early signs of efficacy in psoriasis. keokalani'nui-5/7/2004
474For a while now - Message 18944751nigel bates-5/7/2004
473chromos has been working with CAT: biz.yahoo.comjim heger-5/7/2004
472Ha ! Thought it would be fun to stress-test any fellow shareholders.nigel bates-5/6/2004
471Good gracious that headline just about made me ill. What a poor choice of wordskeokalani'nui-5/6/2004
470European regulators support Abbott's Humira claim Thursday May 6, 6:27 am ETnigel bates-5/6/2004
469Abbott Reports 13.9 Percent Sales Increase in the First Quarter Thursday April 8nigel bates-4/8/2004
468Dunno....someone realised that CAT was valued at less than DYAX ?nigel bates-4/7/2004
467CAT up 6% in london on strong volume. see anything?Madharry-4/7/2004
466Lymphostat-B(TM) selected for Participation in FDA's Continuous Marketing Apnigel bates-3/5/2004
465This isn't the reason, but I've been meaning to mention that someone--makeokalani'nui-3/1/2004
464I wonder if that includes the genzyme purchase. I was curious about the strong vMadharry-3/1/2004
463CAT up 7% this morning on steady buying. Might be something to do with a weekennigel bates-3/1/2004
462>>Mol Cancer Ther. 2003;2:1273-1284 © 2003 American Association for Ctuck-2/19/2004
461From Briefing.com this morning: >>AG Edwards downgrades Cambridge Antibodtuck-2/17/2004
460>> It is tempting to speculate that soluble TRAIL may not be able to engagscaram(o)uche-2/11/2004
459Cambridge Antibody Technology Grants License to Wyeth Wednesday February 11, 8:0nigel bates-2/11/2004
458 This free full text article implicates TRAIL in hepatic disease. Unclear to mtuck-2/11/2004
457Abbott Laboratories <i>(chiselling a**holes)</i> Announce Positive nigel bates-2/9/2004
456CAT shares down after mixed trial results By David Firn, Pharmaceuticals and Chenigel bates-2/9/2004
455Cambridge Antibody Technology Group plc Announces First Quarter Financial Resultnigel bates-2/9/2004
454Cambridge Antibody Technology and Genzyme Announce Preliminary Results From Phasnigel bates-2/9/2004
453It's not just me, then. <g> Recent survey of pharmas' collaboratinigel bates-2/8/2004
452From today's Briefing.com: >>2:01PM Abbott Labs initiates Phase III ttuck-2/4/2004
451GENZ advertising for "Phage Display Specialists" for their new researcnigel bates-1/29/2004
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News